United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12( g ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR
SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15( d )
OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File No. 0-22710                  

Interpharm Holdings, Inc.
(Exact name of registrant as specified in its charter)

75 Adams Avenue, Hauppauge, New York 11788     Tel. 631-952-0214
(Address, including zip code, and telephone number, including
area code, of registrant’s principal executive offices)

Common Stock, par value $.01 per share; Series A Preferred Stock, par value $.01 per share
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty
to file reports under Section 13(a) or 15(d) remains)

Please place an [x] in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)(i)
x
 
Rule 12h-3(b)(1)(i)
x
Rule 12g-4(a)(1)(ii)
o
 
Rule 12h-3(b)(1)(ii)
o
Rule 12g-4(a)(2)(i)
o
 
Rule 12h-3(b)(2)(i)
o
Rule 12g-4(a)(2)(ii)
o
 
Rule 12h-3(b)(2)(ii)
o
     
Rule 15d-6
o

Approximate number of holders of record as of the certification or notice date:        267       

Pursuant to the requirements of the Securities Exchange Act of 1934, Interpharm Holdings, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.


  Interpharm Holdings, Inc.
   
Dated: 5/13/2008                         
By: Peter Giallorenzo, CFO                            

Interpharm (CE) (USOTC:IPAH)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse Interpharm (CE)
Interpharm (CE) (USOTC:IPAH)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse Interpharm (CE)